Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
Clinical trial NCT03388372 · COMPLETED
Trial details
- NCT number
- NCT03388372
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-18
- Primary completion
- 2017-03-23
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.